Literature DB >> 11967284

The fluorescent probe Bodipy-FL-verapamil is a substrate for both P-glycoprotein and multidrug resistance-related protein (MRP)-1.

Enrico Crivellato1, Luigi Candussio, Anna M Rosati, Fiora Bartoli-Klugmann, Franco Mallardi, Giuliana Decorti.   

Abstract

Several fluorescent probes have been used in functional studies to analyze drug transport in multidrug-resistant cells by fluorescent microscopy. Because many of these molecules have some drawbacks, such as toxicity, nonspecific background, or accumulation in mitochondria, new fluorescent compounds have been proposed as more useful tools. Among these substances, Bodipy-FL-Verapamil, a fluorescent conjugate of the drug efflux blocker verapamil, has been used to study P-glycoprotein activity in different cell types. In this study we tested by fluorescent microscopy the accumulation of Bodipy-FL-Verapamil in cell lines that overexpress either P-glycoprotein (P-gp) or multidrug resistance-related protein 1 (MRP1). Expression of P-gp and MRP1 was evaluated at the mRNA level by RT-PCR technique and at the protein level by flow cytometric analysis using C219 and MRP-m6 monoclonal antibodies. Results indicate that Bodipy-FL-Verapamil is actually a substrate for both proteins. As a consequence, any conclusion about P-gp activity obtained by the use of Bodipy-FL-Verapamil as fluorescent tracer should be interpreted with caution.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11967284     DOI: 10.1177/002215540205000514

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  9 in total

Review 1.  Transport in technicolor: mapping ATP-binding cassette transporters in sea urchin embryos.

Authors:  Tufan Gökirmak; Lauren E Shipp; Joseph P Campanale; Sascha C T Nicklisch; Amro Hamdoun
Journal:  Mol Reprod Dev       Date:  2014-08-22       Impact factor: 2.609

Review 2.  Imaging the pharmacology of nanomaterials by intravital microscopy: Toward understanding their biological behavior.

Authors:  Miles A Miller; Ralph Weissleder
Journal:  Adv Drug Deliv Rev       Date:  2016-06-04       Impact factor: 15.470

3.  Blood-to-Retina Transport of Fluorescence-Labeled Verapamil at the Blood-Retinal Barrier.

Authors:  Yoshiyuki Kubo; Ayumi Nakazawa; Shin-Ichi Akanuma; Ken-Ichi Hosoya
Journal:  Pharm Res       Date:  2018-03-12       Impact factor: 4.200

4.  Synthesis of 3,8-dichloro-6-ethyl-1,2,5,7-tetramethyl-BODIPY from an asymmetric dipyrroketone and reactivity studies at the 3,5,8-positions.

Authors:  Ning Zhao; M Graça H Vicente; Frank R Fronczek; Kevin M Smith
Journal:  Chemistry       Date:  2015-03-11       Impact factor: 5.236

5.  Fluorescent substrates for flow cytometric evaluation of efflux inhibition in ABCB1, ABCC1, and ABCG2 transporters.

Authors:  J Jacob Strouse; Irena Ivnitski-Steele; Anna Waller; Susan M Young; Dominique Perez; Annette M Evangelisti; Oleg Ursu; Cristian G Bologa; Mark B Carter; Virginia M Salas; George Tegos; Richard S Larson; Tudor I Oprea; Bruce S Edwards; Larry A Sklar
Journal:  Anal Biochem       Date:  2013-03-05       Impact factor: 3.365

6.  Localization and substrate selectivity of sea urchin multidrug (MDR) efflux transporters.

Authors:  Tufan Gökirmak; Joseph P Campanale; Lauren E Shipp; Gary W Moy; Houchao Tao; Amro Hamdoun
Journal:  J Biol Chem       Date:  2012-11-02       Impact factor: 5.157

7.  Synthesis and regioselective functionalization of perhalogenated BODIPYs.

Authors:  Ning Zhao; Sunting Xuan; Brandon Byrd; Frank R Fronczek; Kevin M Smith; M Graça H Vicente
Journal:  Org Biomol Chem       Date:  2016-06-02       Impact factor: 3.876

8.  (R)-[(11)C]verapamil is selectively transported by murine and human P-glycoprotein at the blood-brain barrier, and not by MRP1 and BCRP.

Authors:  Kerstin Römermann; Thomas Wanek; Marion Bankstahl; Jens P Bankstahl; Maren Fedrowitz; Markus Müller; Wolfgang Löscher; Claudia Kuntner; Oliver Langer
Journal:  Nucl Med Biol       Date:  2013-07-08       Impact factor: 2.408

9.  In vivo imaging of multidrug resistance using a third generation MDR1 inhibitor.

Authors:  Melissa M Sprachman; Ashley M Laughney; Rainer H Kohler; Ralph Weissleder
Journal:  Bioconjug Chem       Date:  2014-05-14       Impact factor: 4.774

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.